| Financial Year |
March 31 2023 |
| Monetary Funds |
270,759,252.71 |
| Held-for-trading Financial Assets |
7,000,052.06 |
| Notes Receivable |
-- |
| Accounts Receivable |
109,006,211.32 |
| Advances to Suppliers |
344,191,254.16 |
| Other Receivables |
239,951,327.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,092,265.00 |
| Inventories |
337,930,149.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
28,242,692.90 |
| Other Current Assets |
35,641,411.96 |
| Total Current Assets |
1,372,722,351.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
67,031,049.82 |
| Long-term Equity Investment |
1,609,774,834.40 |
| Investment Properties |
33,280,455.20 |
| Fixed Assetes |
616,836,662.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,341,775.26 |
| R&D expenses |
-- |
| Goodwill |
159,127,906.98 |
| Long-Term Deferred and Prepaid Expenses |
55,472,654.05 |
| Deferred Income Tax Assets |
134,587,657.97 |
| Other Non-Current Assets |
348,987.10 |
| Sub-Total of Non-Current Assets |
3,768,220,796.51 |
| Total Assets |
5,140,943,148.32 |
| Short-Term Loans |
561,481,657.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
488,553,852.95 |
| Accounts Received In Advance |
21,372,622.20 |
| Employee Compensation Payable |
19,658,916.79 |
| Taxes Payable |
20,654,543.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
387,434,447.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
973,959,663.74 |
| Other Current Liabilities |
7,094,378.81 |
| Sub-Total of Current Liabilities |
2,764,826,533.81 |
| Long-term Loans |
39,739,289.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
210,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
44,917,942.68 |
| Other Non-Current Liabilities |
165,269,236.35 |
| Sub-Total of Non-Current Liabilities |
942,482,658.91 |
| Total Liabilities |
3,707,309,192.72 |
| Paid-In Capital(Or Share Stock) |
2,774,505,919.00 |
| Capital Surplus |
2,473,105,546.22 |
| Surplus Reserve |
448,694,498.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,587,559,190.36 |
| Minority Stockholder's Interest |
189,376,669.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,244,257,286.24 |
| Owner's Equity（Stockholder's Equity） |
1,433,633,955.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,140,943,148.32 |
